Jeffrey J. Bednarski, Ph.D.
Affiliations: | 2003 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancerGoogle:
"Jeffrey Bednarski"Mean distance: 8.64 | S | N | B | C | P |
Parents
Sign in to add mentor| Gary D. Glick | grad student | 2003 | University of Michigan | |
| (Modulation of activation -induced cell death in lymphocytes by a pro-apoptotic benzodiazepine.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Johnston R, Mathias B, Crowley SJ, et al. (2022) Nuclease-independent functions of RAG1 direct distinct DNA damage responses in B cells. Embo Reports. e55429 |
| Johnston R, White LS, Bednarski JJ. (2022) Assessing DNA Damage Responses Using B Lymphocyte Cultures. Methods in Molecular Biology (Clifton, N.J.). 2444: 69-80 |
| Bhatt ST, Bednarski JJ. (2020) Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders. Frontiers in Immunology. 11: 1988 |
| Blincoe A, Heeg M, Campbell PK, et al. (2020) Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology |
| Chan AY, Leiding JW, Liu X, et al. (2020) Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Frontiers in Immunology. 11: 239 |
| Keller MD, Hanley PJ, Zhang N, et al. (2020) Third-Party Virus-Specific T-Cell Infusion for Treatment of Refractory Viral Infections: Interim Results from PBMTC SUP1701 Biology of Blood and Marrow Transplantation. 26: S89-S90 |
| Thakar MS, Logan B, Buckley RH, et al. (2020) Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC) Biology of Blood and Marrow Transplantation. 26: S18-S19 |
| Greenberg ZJ, Monlish DA, Bartnett RL, et al. (2019) The Tetraspanin CD53 Regulates Early B Cell Development by Promoting IL-7R Signaling. Journal of Immunology (Baltimore, Md. : 1950) |
| Soodgupta D, White LS, Yang W, et al. (2019) RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex. Cell Reports. 29: 829-843.e5 |
| Bhatt ST, Schulz G, Hente M, et al. (2019) A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease. Pediatric Blood & Cancer. e28030 |